Skip to content

Effect of Dose Variations of High-Power Laser Therapy on Patients With Nonspecific Cervical Pain

Effect of Dose Variations of High-Power Laser Therapy on Patients With Nonspecific Cervical Pain

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07196800
Enrollment
60
Registered
2025-09-29
Start date
2025-03-10
Completion date
2025-12-01
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain

Brief summary

Nonspecific neck pain, defined as pain without a specific underlying pathology, is a common musculoskeletal disorder that affects a significant proportion of the global population. Neck pain often results in considerable discomfort and functional limitations, impacting individuals' quality of life and ability to perform daily tasks. Estimates suggest that up to 30% of adults experience neck pain annually. The condition ranks among the top causes of disability worldwide, contributing to substantial personal and societal burdens, including lost work productivity and increased healthcare costs.

Interventions

RADIATIONHigh intensity laser therapy (low dose) combined with conventional physiotherapy program

840 joules delivered during each session combined with conventional physiotherapy program Participants

PROCEDUREHigh intensity laser therapy (High dose) combined with conventional physiotherapy program

2632 joules delivered during each session combined with conventional physiotherapy program

Sponsors

Deraya University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* unilateral or bilateral CNP * Experiencing moderate to severe neck pain, defined as a Visual Analog * Scale (VAS) score of ≥4. * Cervical Range of Motion (ROM) Limitation: Documented restriction in cervical ROM compared to normal values for age and gender, to ensure the condition's impact on functional mobility * Patients agreed not to take any medication(anti-inflammatories, analgesics, or muscle relaxants) throughout the course of the study or receive any type of treatment for neck pain

Exclusion criteria

* Previous Cervical Surgery: Patients with a history of cervical spine surgery will be excluded to eliminate potential influences from post-surgical changes on the outcomes * Diagnosed with cervical disc prolapse as confirmed by clinical evaluation and imaging studies (MRI or CT scans). * History of malignancy in the cervical region or other serious medical conditions. * Severe comorbidities that may affect treatment outcomes (e.g., uncontrolled diabetes, cardiovascular diseases). * Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frameDescription
Pain assessment4 weekswhere participants will rate their pain on a scale from 0 (no pain) to 10 (worst pain imaginable).
Cervical Range of Motion (ROM):4 weeksROM will be measured using an OB goniometer in three planes

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026